Detalhe da pesquisa
1.
Phase I study and biomarker analysis of lapatinib and concurrent radiation for locally advanced breast cancer.
Oncologist
; 17(12): 1496-503, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23006498
2.
Comparison of three concomitant boost techniques for early-stage breast cancer.
Int J Radiat Oncol Biol Phys
; 64(1): 168-75, 2006 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16198507
3.
Post-chemotherapy gross tumor volume is predictive of survival in patients with stage III non-small cell lung cancer treated with combined modality therapy.
Lung Cancer
; 52(1): 67-74, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16499996
4.
Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer.
J Clin Oncol
; 22(23): 4837-45, 2004 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15570087
5.
Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage IIIA and IIIB non-small-cell lung cancer: a dose-escalation phase I trial.
J Clin Oncol
; 22(21): 4341-50, 2004 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15514375
6.
High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial.
Int J Radiat Oncol Biol Phys
; 54(2): 348-56, 2002 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12243807
7.
Seeking a home for a PET, part 1: Defining the appropriate place for positron emission tomography imaging in the diagnosis of pulmonary nodules or masses.
Chest
; 125(6): 2294-9, 2004 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15189954
8.
Seeking a home for a PET, part 2: Defining the appropriate place for positron emission tomography imaging in the staging of patients with suspected lung cancer.
Chest
; 125(6): 2300-8, 2004 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15189955
9.
Induction chemotherapy with carboplatin, irinotecan, and paclitaxel followed by high dose three-dimension conformal thoracic radiotherapy (74 Gy) with concurrent carboplatin, paclitaxel, and gefitinib in unresectable stage IIIA and stage IIIB non-small cell lung cancer.
J Thorac Oncol
; 3(3): 250-7, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18317067